Aurion Biotech Expands Its Leadership Team

SEATTLE, BOSTON & TOKYO--(BUSINESS WIRE)--Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, today announced it has appointed Sherita Hall as vice president, clinical operations and Sterling Chung as vice president, global regulatory affairs. “I’m delighted to welcome Sherita and Sterling to Aurion Biotech,” said Greg Kunst, Aurion Biotech chief executive officer. “Their strategic and operational expertise in Regulatory Affa